Change Healthcare Inc. (CHNG) Tops Q2 EPS by 7c

Change Healthcare Inc. (NASDAQ: CHNG) reported Q2 EPS of $0.32, $0.07 better than the analyst estimate of $0.25. Revenue for the quarter came in at $755.9 million versus the consensus estimate of $738.75 million.

“Our second quarter results reflect continued improvement in both healthcare utilization in the U.S. and underlying momentum across our business. The strong support of our customers in expanding their business with us, as well as the penetration of new solutions with both existing and new customers, contributed to our strong results,” said Neil de Crescenzo, president and chief executive officer. “The pandemic has underscored the need for greater efficiency, improved access and enhanced consumer experience across the healthcare continuum. Change Healthcare remains committed to continuing to deliver value to our customers and shareholders by leveraging the strength of our platform, which has the scale, data intelligence, connectivity, interoperability, and user experience capabilities to accelerate innovation and performance.”

GUIDANCE:

Change Healthcare Inc. sees Q3 2021 EPS of $0.28-$0.33, versus the consensus of $0.29. Change Healthcare Inc. sees Q3 2021 revenue of $725-745 million, versus the consensus of $779.06 million.

For earnings history and earnings-related data on Change Healthcare Inc. (CHNG) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• INVO Fertility (IVF) Tops Q2 EPS by 105c